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Previous studies suggest that smooth Brucella organisms inhibit macrophage apoptosis. In contrast, necrotic
cell death of macrophages infected with rough Brucella organisms in vitro has been reported, which may in part
explain the failure of some rough organisms to thrive. To characterize these potential macrophage killing
mechanisms, J774.A1 murine macrophages were infected with Brucella abortus S2308-derived rough mutant
CA180. Electron microscopic analysis and polyethylene glycol protection assays revealed that the cells were
killed as a result of necrosis and oncosis. This killing was shown to be unaffected by treatment with carben-
icillin, an inhibitor of bacterial cell wall biosynthesis and, indirectly, replication. In contrast, chloramphenicol
treatment of macrophages infected at multiplicities of infection exceeding 10,000 prevented cell death, despite
internalization of large numbers of bacteria. Similarly, heat-killed and gentamicin-killed CA180 did not induce
cytopathic effects in the macrophage. These results suggested that killing of infected host cells requires active
bacterial protein synthesis. Cytochalasin D treatment revealed that internalization of the bacteria was neces-
sary to initiate killing. Transwell experiments demonstrated that cell death is not mediated by a diffusible
product, including tumor necrosis factor alpha and nitric oxide, but does require direct contact between host
and pathogen. Furthermore, macrophages preinfected with B. abortus S2308 or pretreated with B. abortus O
polysaccharide did not prevent rough CA180-induced cell death. In conclusion, Brucella rough mutant infection
induces necrotic and oncotic macrophage cell death that requires bacterial protein synthesis and direct
interaction of bacteria with the target cells.
Brucella spp. are facultative intracellular bacteria that cause
brucellosis in a variety of animals and undulant fever in hu-
mans. The disease is one of the most widespread zoonoses in
the world, especially in developing countries (7). Six species
have been described, but only Brucella melitensis, B. abortus,
and B. suis pose a threat to public health. Therefore, these
species have been classified as category B agents that can be
used as biological weapon (35). Although the disease has been
described in humans for more than 100 years, its virulence
mechanisms remain largely undefined.
Macrophages are the primary target cells in which Brucella
organisms multiply and cause persistent infection. In addition,
the bacteria infect a variety of nonprofessional phagocytes,
including NIH 3T3, HeLa, Vero, DMCK, and BHK cells (50).
The bacteria also invade trophoblast cells and cause abortion
in ruminants (5, 45). It is well accepted that survival of Brucella
in host macrophages determines virulence and contributes to
disease pathogenesis (41). The majority of rough Brucella mu-
tants are attenuated for virulence due to reduced survival in
host cells, but B. canis and B. ovis are two exceptions (11).
Recent studies have revealed that rough derivatives of Brucella
may survive and multiply in host cells (25, 26, 48, 56). The
significance of these observations may reside in the nature of
the genetic defects responsible for rough character. Associated
with these differences are numerous studies showing that
rough Brucella infection results in macrophage death (17, 21–
23, 48). However, it is unclear how macrophages are killed and
how the killing mechanisms contribute to disease pathogenesis.
As the front line of the innate immune response, macro-
phages ingest and kill invading pathogens, produce various
cytokines, and perform antigen presentation to develop adap-
tive immunity. Successful pathogens must develop strategies to
avoid innate and adaptive immune responses. One key strategy
used by pathogens is production of specific factors that control
the fate of the infected host. Some pathogens, such as Salmo-
nella (8, 10, 33, 42, 46), Shigella flexneri (32, 61), and Mycobac-
terium tuberculosis (13), induce macrophage cell death via apop-
tosis or necrosis, presumably favoring bacterial spread in the
host. Other pathogens, such as Brucella (17, 24, 29, 55, 59),
Chlamydia (19, 20), Bartonella henselae (36), low-dose Myco-
bacterium tuberculosis, and Mycobacterium bovis (BCG) (15,
38) inhibit host cell apoptosis, favoring bacterial survival by
escaping host immune surveillance.
Virulence factors that mediate cell death have been identi-
fied in some bacterial pathogens (28). The Salmonella patho-
genicity island 1-encoded SipB protein is responsible for the
induction of macrophage apoptosis after Salmonella infection
(31, 52). In Shigella flexneri, IpaB protein secreted by a type III
secretion system binds to and activates caspase 1, which in-
duces host cell apoptosis (32, 60, 61). Unlike the case for other
pathogenic bacteria, classical virulence factors such as exotox-
ins, cytolysins, capsules, fimbriae, flagella, virulence plasmids,
lysogenic phages, resistance forms, and antigenic variation are
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missing from Brucella (27). Our recent studies have confirmed
previous reports describing cell death of macrophages infected
with rough Brucella organisms in vitro (17, 21, 23), and cell
death appears to result from necrosis, not apoptosis (48). How-
ever, the mechanisms and virulence factors that mediate mac-
rophage cell death have not been identified, and it is not clear
whether this is a property that is restricted to rough organisms
or is enhanced as a result of changes in the bacterial mem-
brane.
To characterize the mechanisms and factors responsible for
macrophage cell death, we used murine J774.A1 macrophages
infected with the rough Brucella mutant CA180 as a model and
demonstrated that macrophages were killed by necrotic and
oncotic cell death. Macrophage killing by rough Brucella mu-
tants is shown to require bacterial protein synthesis and direct
interaction of live bacteria with macrophages.
MATERIALS AND METHODS
Bacterial strains. The bacteria used in these experiments include B. abortus
virulent strain S2308; rough mutant CA180, derived from S2308 by transposon
insertion in manA, encoding phosphomannomutase (BMEII0899) (3); CA180
complemented by pBBR1MCS6-Y::ManBA, expressing phosphomannomutase;
and CA180 with empty vector pBBR1MCS6-Y. Bacteria were grown on tryptic
soy agar plates with or without antibiotic, as appropriate, and prepared for
inoculation as described previously (48). Killed bacteria were obtained by incu-
bating cultures at 60°C in a water bath for 2 h or by incubating for 1 h at room
temperature in medium supplemented with 50 g/ml gentamicin. The viability of
the bacteria was evaluated by growth on tryptic soy agar at 37°C for 5 days.
Cell culture and reagents. Murine macrophage-like cell line J774.A1 (ATCC
TIB-67) was maintained in Dulbecco’s modified Eagle’s medium (DMEM) with
10% fetal bovine serum and 0.1 mM nonessential amino acids (complete
DMEM) as previously described (48). The cells were passaged every 3 to 5 days
and discarded after passage 15. Cytochalasin D and the inducible nitric oxide
synthase inhibitor, L-NAME (N--nitro-L-arginine methyl ester), were pur-
chased from Sigma (St. Louis, MO). Goat anti-murine tumor necrosis factor
alpha (TNF-) and goat immunoglobulin G (IgG) control were purchased from
PeproTech Inc. (Rocky Hill, NJ). CytoTox 96 nonradioactive cytotoxicity assay
kits were purchased from Promega (Madison, Wis.). B. abortus O polysaccharide
(OPS) was kindly provided by J. W. Cherwonogrodzky (Department of National
Defense, Alberta, Canada).
Macrophage infection. Monolayers of J774.A1 macrophages cultured in 24-
well plates were infected with B. abortus at a multiplicity of infection (MOI) of
100 as described previously (48). For mixed infections, J774.A1 cells were in-
fected with S2308 and CA180 at a ratio of 1:1 and an MOI of 100 for each strain.
For superinfection, J774.A1 macrophages were infected with S2308 at an MOI of
100. After 24 h, the cells were washed twice with DMEM to remove gentamicin
and then superinfected with CA180 at an MOI of 100.
Treatment of macrophages with antibiotics and other reagents. J774.A1 mac-
rophages cultured in 24-well plates were infected with CA180 and incubated with
DMEM containing 50 g/ml gentamicin for 1 h to kill extracellular bacteria (48).
The media were replaced with complete DMEM containing chloramphenicol (30
g/ml) or carbenicillin (50 g/ml) before the plates were incubated for another
24 h. To inhibit bacterial uptake, macrophages were treated with cytochalasin D
(2 g/ml) 1 h prior to and during Brucella infection. To determine the roles of
TNF- and nitric oxide in cell death, CA180-infected macrophages were treated
with L-NAME (5 to 20 mM) or goat anti-mouse TNF- IgG (5 to 20 g/ml).
Similar concentrations of goat IgG were used as controls (34). To determine the
effects of smooth Brucella OPS on the cytopathic effect of rough Brucella infec-
tion in macrophages, J774.A1 cells were treated with smooth B. abortus OPS (10
g/ml) for 2 h prior to the infection with CA180 and over the course of the
infection. Cytopathic cell death was determined via measurement of lactate
dehydrogenase (LDH) release in the cell culture supernatants as previously
described (48).
PEG protection assay. J774.A1 cells cultured in 24-well plates were infected
with CA180 at an MOI of 100 as described above. Following a 1-hour incubation,
growth medium was replaced with complete DMEM containing 50 g/ml gen-
tamicin and 30 mM of polyethylene glycol (PEG) 3350 or PEG 8000. Sucrose (30
mM) was included as a negative control. Supernatants were collected at 24 h
postinfection (p.i.), and LDH release was determined.
Quantitation of cytopathic cell death. Lactate dehydrogenase released into
cell culture supernatants was detected using the CytoTox 96 nonradioactive
cytotoxicity assay as described previously (48). Cell death was expressed as a
percentage of LDH release, which is calculated with the following formula:
percentage of LDH release  100  (test LDH release  spontaneous release)/
(maximum release  spontaneous release).
Transmission electron microscopy (TEM). J774.A1 cells cultured in six-well
plates were infected with S2308 and CA180 as described above. The infected
cells were fixed at various times following infection with 2% (wt/vol) glutaralde-
hyde, 2% (wt/vol) paraformaldehyde, 2% (wt/vol) acrolein, 1.5% (vol/vol) dim-
ethyl sulfoxide in 0.133 mM cacodylate buffer (pH 7.4) for 16 h in 4°C. The
samples were postfixed in 1% (wt/vol) osmium tetroxide and processed at the
Image Analysis Laboratory in the College of Veterinary Medicine and Biomed-
ical Sciences, Texas A&M University. Infected cells were visualized using elec-
tron microscopy (EM 10 CA high-resolution electron microscope; Carl Zeiss,
Inc., Oberkochen, Germany).
Transwell experiments. J774.A1 macrophages cultured in 24-well plates were
infected with CA180 at an MOI of 100. Transwells (VWR, Sugar Land, TX) were
inserted and seeded with macrophages at 105 cells/well without infection. At 24 h
p.i., culture medium was removed. Cells remaining in the 24-well plate and
transwells were lysed with 1% (vol/vol) Triton X-100. The lysates were diluted
with phosphate-buffered saline (pH 7.4), and LDH levels were determined as
described above and previously (48). The cell number remaining was estimated
using a standard curve obtained from lysates of various concentrations of
J774.A1 macrophages.
Statistical analysis. Statistical significance was determined using Student’s t
test for data with two groups and one-way analysis of variance for multiple group
comparison; a P value of 0.05 was considered significant.
RESULTS
Morphological features of macrophage necrosis and oncosis
induced by B. abortus CA180 infection. Our previous studies
have demonstrated that Brucella rough mutant infection in
macrophages results in what is best described as necrotic cell
death (48). To further characterize cell death, J774.A1 macro-
phages infected with Brucella strains S2308 and CA180 were
visualized using TEM. S2308 multiplying in the cell was found
surrounded by a clear zone. Infection with S2308 did not cause
cell death despite massive bacterial multiplication (Fig. 1A). In
contrast, CA180 infection resulted in macrophage cell death in
the absence of large numbers of intracellular bacteria. Char-
acteristics of CA180-infected dying cells included swollen mi-
tochondria, leaking cytoplasmic content, and rarefied nuclei,
which are classical signs of necrosis (Fig. 1B and C). In addi-
tion, we observed that some dead cells exhibited cell and or-
ganelle swelling, which are characteristics of oncosis (18, 44)
(Fig. 1D, E, and F). These results confirmed our previous
report that rough Brucella infection induces macrophage cell
death through necrosis rather than apoptosis or physical de-
struction induced by bacterial multiplication (48). Also, in con-
trast to smooth infection, multiple rough bacteria appear to be
contained within single membrane-bound compartments (Fig.
1B, inset), while smooth organisms were singly encased (Fig.
1A, inset) during the steps preceding cell death.
Pore formation contributes to cell death. Osmotic cell lysis
caused by oncosis can be prevented by addition of carbohy-
drates of different sizes to the cell culture medium (43). PEGs
of different molecular weights have been used to estimate the
pore size on the membrane of cells infected with pathogens,
such as Legionella pneumophila (37), Shigella flexneri (6),
Pseudomonas aeruginosa (12), and Burkholderia pseudomallei
(54). Our previous study showed that CA180 infection induced
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rapid LDH release from macrophages, especially when ele-
vated MOIs were used (48), suggesting pore formation in the
host cell membrane. Transmission electron microscopic obser-
vation suggested that some of the infected cells died from
oncosis (Fig. 1E and F). To confirm this hypothesis, CA180-
infected J774.A1 macrophages were treated with 30 mM of
either sucrose, PEG 3350, or PEG 8000. LDH release was
significantly decreased with PEG 3350 treatment (P  0.001)
and was completely blocked in the presence of PEG 8000 (P 
0.001). In contrast, sucrose treatment had no effect on macro-
phage death (Fig. 2). These data support the hypothesis that
CA180 infection induces pore formation in macrophage mem-
branes, resulting in oncotic cell death.
Cytotoxicity induced by CA180 infection is prevented by
expression of phosphomannomutase by trans complementa-
tion. The disruption of manBA, encoding phosphomanno-
mutase, by Tn5 transposon insertion in CA180 prevents core
oligosaccharide biosynthesis (3). In an effort to restore wild-
type lipopolysaccharide production, CA180 was transformed with
pBBR1MCS6-Y::manBA expressing phosphomannomutase. Ex-
pression of O antigen was confirmed by Western blotting, colonial
crystal violet staining, and acriflavin agglutination (data not
shown). trans complementation of CA180 with pBBRMCS6-
Y::manBA restored the smooth phenotype and prevented cy-
totoxicity (P 0.001), while infection with CA180 transformed
with the empty vector released levels of LDH identical to those
released by CA180-infected macrophages (P 	 0.05) (Fig. 3).
These results demonstrate that the cytotoxicity of CA180 to
macrophages is due to the failure to express phosphmanno-
mutase in the transposon mutant.
Macrophage cell death requires viable bacteria and bacte-
rial protein synthesis. Since macrophage cell death did not
accompany massive bacterial multiplication (48), we wanted to
determine if cell death was a result of direct interaction with
FIG. 1. Ultrastructure of macrophages infected with Brucella. (A) J774.A1 macrophages infected with S2308 at an MOI of 10 and fixed at 48 h
p.i. (B) J774.A1 macrophages infected with CA180 at an MOI of 10 and fixed at 48 h p.i. (C to F) J774.A1 macrophages infected with CA180 at
an MOI of 100 and fixed at 24 h p.i. The samples were observed using transmission electron microscopy. Bar, 1 m.
FIG. 2. CA180 infection induces pore formation on macrophage
membranes. J774.A1 macrophages were infected with CA180 at an
MOI of 100. The infected cells were treated with complete DMEM
containing 30 mM sucrose, PEG 3350, or PEG 8000. The LDH release
was detected at 24 h p.i. The results are from three independent
experiments.
FIG. 3. Complementation of cytotoxicity induced by CA180 infec-
tion. J774.A1 macrophages were infected with S2308, CA180, comple-
mented CA180-ManBA, and CA180 with empty vector (CA180-vec-
tor) at an MOI of 100. Cell death caused by the infection was
determined by LDH release. The results are from three independent
experiments.
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the Brucella rough mutant. J774.A1 cells were inoculated with
heat-killed and gentamicin-killed CA180 at an MOI of 100.
Although the killed bacteria were internalized as efficiently as
live bacteria as visualized by microscopic immunofluorescence
(data not shown), the macrophages did not exhibit any cyto-
pathic effect (Fig. 4). These results indicate that stimulation of
the host cell does not occur due to internalization of a large
number of dead bacteria; instead, the bacteria must be viable.
Therefore, it was hypothesized that bacterial factors responsi-
ble for cell death are actively produced during infection.
To characterize the factors, J774.A1 macrophages were in-
fected with CA180 at an MOI of 10 and treated with chloram-
phenicol and carbenicillin. Chloramphenicol treatment inhibits
bacterial protein synthesis and, therefore, bacterial multiplica-
tion. Carbenicillin inhibits bacterial cell wall synthesis and rep-
lication but not protein synthesis. The use of both antibiotics
helps to rule out replication as the critical factor causing cyto-
toxic cell death. Bacterial replication was evaluated at 24 h p.i.
based on viable bacterial (CFU) recovery. In either chloram-
phenicol- or carbenicillin-treated cells, CA180 multiplication
was undetectable (Fig. 5A). These results were confirmed by
immunofluorescence staining of the infected cells (data not
shown). LDH levels in cell culture supernatants revealed that
chloramphenicol treatment, which inhibits bacterial protein
synthesis and replication, prevented macrophage cell death
(Fig. 5B). However, carbenicillin treatment, which inhibits bac-
teria cell wall synthesis and replication but not protein synthe-
sis, did not completely inhibit macrophage cell death; 18.9% of
FIG. 4. Killed Brucella organisms do not induce macrophage cell
death. J774.A1 macrophages were inoculated with heat-killed (HK-)
and gentamicin-killed (Gm-) CA180 at an MOI of 100. The superna-
tants were collected at 24 h postinoculation, and LDH release was
detected by CytoTox 96 nonradioactive cytotoxicity assay. The results
are from three independent experiments.
FIG. 5. Macrophage killing by CA180 infection requires bacterial protein synthesis, not multiplication. J774.A1 macrophages infected with
CA180 at an MOI of 100 were incubated for 1 h with DMEM containing 40 g/ml of gentamicin (Gm), and then the media were replaced with
DMEM containing chloramphenicol (Cm) (30 g/ml) or carbenicillin (Cb) (50 g/ml). (A) Bacterial multiplication was determined by CFU
recovery at 24 h p.i. (B) LDH levels were detected by CytoTox 96 nonradioactive cytotoxicity assay at 24 h p.i. (C) J774.A1 macrophages were
infected with CA180 at an MOI of 100, 1,000, or 10,000, and the media were replaced with DMEM containing 30 g/ml of chloramphenicol. LDH
release was detected at 24 h p.i. (D) J774.A1 macrophages were infected with CA180 at an MOI of 100, and the media were replaced with DMEM
containing 30 g/ml of chloramphenicol at the indicated time points p.i.; LDH release was detected at 24 h p.i. The results are from three to four
independent experiments.
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LDH release was detected in carbenicillin-treated cells, com-
pared with 30.9% in untreated cells (P 	 0.05), in experiments
performed at reduced MOIs of 10 to limit the rate at which
lysis occurs (Fig. 5B). The difference in cytotoxicity observed is
attributable to reduced numbers of bacteria for Brucella
treated with carbenicillin (Fig. 5A). To further characterize the
importance of protein synthesis, J774.A1 cells were infected
with CA180 at an MOI of 100, 1,000, or 10,000 and treated
with chloramphenicol, and LDH release in the supernatants
was determined at 24 h p.i. Once again, chloramphenicol treat-
ment prevented the cytopathic effect of CA180 infection in
murine macrophages, even when cells were infected at an MOI
of 10,000 (Fig. 5C). In order to rule out effects of chloram-
phenicol on macrophages (40), J774.A1 cells were pretreated
with chloramphenicol (60 g/ml) for 24 h and washed with
DMEM prior to CA180 infection. LDH release detected at
20 h p.i. revealed that pretreatment of macrophages with
chloramphenicol did not affect CA180-induced macrophage
cell death (data not shown). Taken together, these data
demonstrated that bacterial protein synthesis is critical for
cytotoxicity.
To provide preliminary insight regarding the nature of the
bacterial component responsible and the timing of its expres-
sion, chloramphenicol (30 g/ml) was added at different time
points following infection with CA180 at an MOI of 100. LDH
release detected at 24 h p.i. was blocked completely by adding
chloramphenicol within 4 h p.i. An increased release of LDH
(23.2%) was detected when chloramphenicol was added at 6 h
p.i.; however, this value is not significantly different from LDH
release at the earlier time points (P 	 0.05). Chloramphenicol
addition at 8 h p.i. resulted in 32.0% release of LDH, which is
significantly different from release at earlier time points (P 
0.05) but not significantly different from LDH release from
gentamicin-treated control macrophages (P 	 0.05) (Fig. 5D).
These results suggest that the factor(s) was produced or
accumulated to effective levels by approximately 6 to 8 h p.i.,
a time corresponding to a point when virulent Brucella or-
ganisms have theoretically adjusted to the intracellular en-
vironment (9).
Macrophage activation is not the cause of cell death. It has
been shown that rough Brucella infection activates macro-
phages and induces proinflammatory cytokine production, in-
cluding that of nitric oxide and TNF- (34, 51). TNF- and
nitric oxide are produced as a result of CA180 infection in
J774.A1 macrophages (data not shown). The possibility existed
that necrotic cell death was mediated by TNF- induced by
CA180 infection in an autocrine/paracrine fashion or that cell
death was due to hyperactivation of the macrophages by nitric
oxide. To rule out these possibilities, J774.A1 cells were in-
fected with CA180 at an MOI of 100 and treated with L-
NAME or goat anti TNF- (34). LDH release detected at 24 h
p.i. revealed that L-NAME and anti-TNF- antibody treat-
ments did not affect macrophage cell death (Fig. 6), sug-
gesting that TNF- and nitric oxide were not involved in the
cytotoxicity.
Cytotoxic cell death induced by Brucella requires macro-
phage uptake. The previous sections reveal that macrophage
killing induced by CA180 infection required bacterial protein
synthesis but not TNF- and nitric oxide. To determine
whether the unknown protein factors were released from the
infected cells, a transwell study was performed (Fig. 7). The
numbers of live cells recovered from infected and uninfected
bottom wells were 0.052  106
 0.027  106/ml and 1.377 
106
 0.065  106/ml, respectively; 96% of the cells were killed
by CA180 infection. However, the live cell numbers in the
insert wells with infected and uninfected bottom wells were
0.983  106
 0.07  106/ml and 1.033  106
 0.045  106/ml,
respectively (P	 0.05) (Fig. 7). These results demonstrate that
the unknown macrophage killing factors were not able to dif-
fuse from the infected cell layer. This result was consistent with
the observation of individual dead cells in monolayers infected
with CA180 at an MOI of 10 (data not shown).
It has been well established that cytochalasin D inhibits actin
polymerization and therefore bacterial invasion of mammalian
cells (2, 30). Invasion of macrophages by Brucella can be sim-
ilarly inhibited by cytochalasin D treatment (39). To determine
whether the killing mechanisms require internalization of the
bacteria, J774.A1 cells were pretreated with cytochalasin D (2
g/ml) for 1 h before CA180 infection at an MOI of 50 or 500.
FIG. 6. Roles of TNF- and nitric oxide in macrophage cell death
induced by CA180 infection. J774.A1 macrophages were infected with
CA180 at an MOI of 100 and treated with L-NAME and goat anti-
mouse TNF-. The viability of the macrophages was determined by
detecting LDH release at 24 h p.i. The results are from three inde-
pendent experiments.
FIG. 7. Macrophage cell death induced by CA180 infection re-
quires direct interaction of bacteria and macrophages. J774.A1 mac-
rophages cultured in a 24-well plate were infected with CA180 at an
MOI of 100. A transwell seeded with J774.A1 without infection was
inserted. The surviving cells in the 24-well plate and transwells were
lysed with 1% Triton X-100 at 24 h p.i. LDH release was detected, and
the corresponding cell numbers were determined with a standard curve
obtained from a serially diluted cell suspension with known concen-
trations. The data shown are representative of two independent ex-
periments with similar results. Error bars indicate standard deviations.
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The infected cells were incubated with DMEM containing
gentamicin (40 g/ml) for 24 h, and LDH release in the su-
pernatants was detected. Cytochalasin D treatment dramati-
cally reduced cell death, showing that bacterial internalization
is required to initiate the killing mechanisms (Fig. 8).
Smooth Brucella infection and smooth Brucella OPS do not
inhibit CA180 infection-induced macrophage cell death. It has
been reported that smooth Brucella infection inhibits apoptosis
in macrophages in vitro and in vivo (17, 24, 29, 55, 59). Al-
though antiapoptotic activity of Brucella in J774.A1 macro-
phages has not been reported, infection with an MOI of 100 of
S2308 did not result in J774.A1 cell death (48). Our recent
study also showed that smooth Brucella organisms do not ac-
tivate macrophages in terms of NF-B p65 translocation and
cytokine and nitric oxide production (unpublished results). To
determine whether smooth Brucella infection prevents induc-
tion of cell death by rough Brucella infection, J774.A1 macro-
phages were infected with a mixture of S2308 and CA180 at an
MOI of 100 for each strain. Previous results indicate that 40%
of the cells are infected with smooth organisms under these
conditions and 100% of the cells are infected with rough or-
ganisms. Infection with either organism has no detectable ef-
fect on the uptake of reinfecting or superinfecting organisms
(data not shown). LDH detection at 24 h p.i. revealed that
S2308 infection did not prevent CA180-induced cell death
(Fig. 9A). Because S2308 invades macrophages in reduced
numbers compared with CA180 (48), many macrophages may
be killed by CA180 before the smooth organisms multiply. To
overcome this potential problem, we infected J774.A1 cells
with S2308 at an MOI of 100 and 24 h later superinfected the
cells with CA180. The results demonstrate that smooth Bru-
cella multiplication did not inhibit rough Brucella-induced cell
death (Fig. 9B). Similarly, Brucella OPS treatment of the mac-
rophages prior to infection with CA180 did not interfere with
cell death (Fig. 9C).
DISCUSSION
It has been demonstrated that some rough derivatives of B.
abortus, B. suis, and B. melitensis are cytotoxic to macrophages
(17, 21–23, 48). However, the mechanisms behind this killing
have not been investigated. Unlike other pathogenic bacteria,
Brucella appears to have few, if any, classical virulence factors
(27). Although putative virulence factors have been identified
as a result of Brucella genomic sequence analysis, most remain
to be verified (14). In this report, we demonstrate for the first
time that Brucella rough mutant CA180 infection in macro-
phages produces a factor(s) that causes necrotic and oncotic
cell death. This factor is not readily diffusible based on trans-
well experiments and microscopic observation of infected cul-
tures. Infection with heat-killed or gentamicin-killed bacteria
did not cause cell death, suggesting that the factor is actively
produced by viable bacteria. Infection of macrophages with
CA180 at elevated MOIs (up to 10,000) followed by treatment
FIG. 8. Internalization of bacteria is necessary for macrophage cell
death. J774.A1 cells were treated with cytochalasin D (2 g/ml) for 1 h
prior to infection with CA180 at an MOI of 50 or 500. LDH release
was detected at 24 h p.i. The data shown are from three independent
experiments.
FIG. 9. Smooth Brucella infection and multiplication in murine
macrophages or Brucella OPS treatment does not prevent CA180
infection-induced cell death. J774.A1 macrophages cultured on 24-well
plates were infected with a mixture of S2308 and CA180 at an MOI of
100 (A), infected with S2308 and superinfected with CA180 at 24 h p.i.
(B), or treated with B. abortus OPS (10 g/ml) and infected with
CA180 (C). LDH release was detected at 24 h p.i. The data shown are
from four independent experiments. Error bars indicate standard de-
viations.
2672 PEI ET AL. INFECT. IMMUN.
 o
n
 Septem
ber 19, 2018 by guest
http://iai.asm
.org/
D
ow
nloaded from
 
with chloramphenicol revealed that the killing mechanism(s)
requires active bacterial protein synthesis. Macrophages were
not killed if bacterial protein synthesis was inhibited within the
first 4 h p.i., indicating that factors induced by Brucella infec-
tion within 4 h are not sufficient to kill the cells or that the
factors are not synthesized until later in infection. Treatment
of infected cells with carbenicillin did not significantly prevent
macrophage cell death, while bacterial multiplication was in-
hibited, suggesting a direct link between cell death and bacte-
rial protein synthesis. The difference in LDH release between
carbenicillin-treated and gentamicin-treated cells was attribut-
able to bacterial growth in gentamicin-treated controls. Fur-
thermore, cytochalasin D pretreatment significantly inhibits
cell death, demonstrating that bacterial internalization is nec-
essary for the killing observed.
Recent studies show that chloramphenicol prevents cell
apoptosis through a p21-dependent pathway (40). Our data
demonstrate that CA180-infected macrophages were killed by
oncosis and necrosis, not by apoptosis. However, to rule out
the possibility that chloramphenicol antiapoptotic effects pre-
vent macrophage killing, CA180 was pretreated with chloram-
phenicol (60 g/ml) and washed with PBS before infecting
macrophages. Since chloramphenicol is a bacteriostatic re-
agent, the bacteria will be revived after removal. Therefore,
chloramphenicol-treated CA180 still induces macrophage cell
death (data not shown). In the macrophage pretreatment ex-
periment, chloramphenicol has to be removed to ensure
proper CA180 infection. However, antiapoptotic effects should
be prolonged, since the half-life of p21 mRNA is 18 h after
chloramphenicol is removed (40). Under the current experi-
mental conditions, CA180-induced cell death can be detected
in chloramphenicol-pretreated cells within 24 h or less, de-
pending on the MOI, and is not significantly different from that
of untreated cells, suggesting that chloramphenicol antiapop-
totic activity is not involved in the cell killing mechanisms.
Four pathways leading to cell death have been described to
date: apoptosis, autophagy, oncosis, and pyroptosis (18). On-
cosis is a prelethal pathway leading to cell death characterized
by cell and organelle swelling, cell blebbing, and increased
membrane permeability (18, 44). A variety of pathogenic mi-
croorganisms have been shown to cause host cell oncosis, in-
cluding bacteria (6, 12, 37, 54) and viruses (49). In the current
study, TEM studies showed that, in addition to necrosis,
CA180-infected macrophages underwent oncosis with charac-
teristics similar to those described above, which confirmed
previous reports that infected cells were not killed via apopto-
sis (48). PEG protection assays suggested that CA180 infection
induces pore formation in the macrophage membrane. These
data revealed for the first time that Brucella rough mutants, or
at least those defective in phosphomannomutase, induced pore
formation in murine macrophages and caused oncotic cell
death.
CA180 is a deep rough mutant derived from S2308 with a
Tn5 insertion in the gene encoding phosphmannomutase, a key
enzyme involved in O-antigen biosynthesis (3). Without O-
antigen expression, some structures of the bacterial surface
may be exposed or altered. Consequently the interaction be-
tween bacteria and host cells may be altered. However, the
results shown demonstrate that contact of the rough bacteria
with host cells was insufficient to kill the cells; instead, the
organisms must be internalized. Furthermore, if bacterial pro-
tein synthesis is inhibited with chloramphenicol, despite the
presence of a large number of internalized organisms, the
macrophage will not be killed. These data indicate that cell
death did not result from the interaction of preexisting bacte-
rial factors or structural components with J774.A1 macro-
phages; the rough bacteria must actively synthesize proteins
after internalization. The obvious questions are whether
smooth Brucella organisms produce such factors and whether
they are important for virulence. One possibility is that pro-
duction of the factor is suppressed or masked in smooth Bru-
cella as a result of O-antigen expression. Therefore, the factor
may be produced only by rough Brucella and be directly related
to the structure of O antigen. This hypothesis is supported by
the observation that different rough Brucella mutants have
different levels of cytotoxicity which are related to their rough
character (48). Proteomic studies and microarray analysis will
help to address this possibility. A second possibility is that the
factor is produced by smooth Brucella but O antigen inhibits
the macrophage killing mechanisms. This hypothesis is sup-
ported by the facts that smooth Brucella organisms do not
activate macrophages (data not shown), but they do inhibit
macrophage or monocyte apoptosis (17, 24, 29, 55, 59). Al-
though there have been no reports of antiapoptotic activity in
J774.A1 after infection with smooth Brucella, our studies have
shown that S2308 infection at an MOI of 100 does not induce
J774.A1 macrophage cell death (48). In contrast, mixed infec-
tion and superinfections with S2308 or exposure to purified
OPS demonstrated no direct effect of smooth organisms or
OPS on cell death induced by rough organisms. These obser-
vations are consistent with the idea that the factor is neither
produced in macrophages infected with smooth Brucella nor
inhibited by their presence. These results support the hypoth-
esis that spontaneous rough mutant generation may induce cell
death and promote Brucella spread.
To rule out the possible role of transposon in macrophage
cell death and demonstrate that the cell death is due to gene
inactivation, we complemented CA180 in trans with the phos-
phmannomutase-expressing plasmid pBBR1MCS6-Y. The
complemented CA180 did not induce cell death, indicating
that phosphmannomutase gene knockout-induced roughness is
responsible for the cell killing.
Although some rough strains of B. abortus, B. suis, and B.
melitensis have been demonstrated to be cytotoxic to macro-
phages in culture (17, 21–23, 48), we found that not all rough
Brucella mutants are cytotoxic to macrophages (data not
shown). The outcomes of infection are most likely determined
by the balance between cell killing mechanisms and survival
ability of rough Brucella in host cells. If the organisms can
reach replication niches and survive, the host cells will be
killed. Otherwise, the bacteria will be cleared by the host cells.
In the current report, we hypothesize that Brucella rough
mutant-caused cell death is mediated by a nonsecreted fac-
tor(s) induced following macrophage infection. Expression of
this factor is not prevented by smooth Brucella infection and
multiplication. Perhaps it is important that the factor is not
secreted to avoid massive destruction of macrophages and in-
duction of strong immune responses. In this case infected mac-
rophage will not be lysed simultaneously; only a few cells con-
taining sufficient rough organisms will be lysed. Therefore, an
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appropriate balance between pathogen and host will be main-
tained.
It is generally accepted that Brucella rough mutants are
attenuated in animal hosts because they are sensitive to killing
factors in body fluids, with the obvious exceptions of the nat-
ural rough species B. ovis and B. canis, which are virulent in
their natural hosts (11). In addition, Fernandez-Prada et al.
have also demonstrated that rough B. melitensis organisms are
not sensitive to complement-mediated lysis (16, 17). In the
TEM study of Brucella-infected cells, we observed that rough
organisms were enclosed within a membrane prior to cell lysis,
suggesting that rough Brucella may be resistant to killing fac-
tors in vivo. The reason for the observed attenuation of rough
Brucella mutants in animal models may be that, after intraper-
itoneal inoculation, the bacteria are killed by factors in ascitic
fluid prior to invasion (unpublished result). Furthermore, bac-
teria wrapped in cellular membrane may be easily recognized
as cell debris and taken up quickly by macrophages, initiating
another round of infection.
Salmonella infection induces macrophage and dendritic cell
death by a mechanism that depends on SipB and the type III
secretion system (57, 58). Although possible type III secretion
gene homologs have been identified in Brucella recently, it is
not clear whether they are functional (1). It has been demon-
strated that a type IV secretion system is present in Brucella
(47); the virulence factors secreted by the type IV secretion
system have not yet been identified. Pore formation is a char-
acteristic property of the Dot/Icm system in Legionella and
causes a similar oncotic cell death in macrophages (4, 53).
However, there are no reports of enhanced activity in the
absence of Legionella O antigen. The significance of this dif-
ference is unknown; however, cytotoxicity is not consistently
observed with all rough Brucella organisms. Thus, it appears
likely that other factors are involved and that their expression
and character may change independently of changes in lipo-
polysaccharide structure.
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